- The report discusses the market performance of various indices, including the Shanghai Stock Exchange 50 Index, which performed well with a rise of 0.58%[6] - The report highlights the performance of sector indices, noting that the banking, comprehensive finance, media, steel, and pharmaceutical industries performed well, with returns of 1.85%, 1.13%, 0.72%, 0.52%, and 0.41%, respectively[7] - The report provides data on market sentiment, including the number of stocks that hit their daily limit up and down, with 41 stocks hitting the limit up and 13 stocks hitting the limit down at the close of trading[12] - The report includes information on the financing and securities lending balance, which stood at 18,591 billion yuan as of July 3, 2025, with a financing balance of 18,464 billion yuan and a securities lending balance of 127 billion yuan[16] - The report discusses the premium and discount rates of ETFs, noting that the innovative drug ETF Huatai Bairui had the highest premium at 0.92%, while the Kechuang New Materials ETF Huatai Bairui had the highest discount at 0.74%[20] - The report provides data on block trading, noting that the average daily transaction amount over the past six months was 1.2 billion yuan, with the transaction amount on July 3, 2025, being 1.8 billion yuan and the average discount rate over the past six months being 5.75%[23] - The report discusses the annualized discount rates of stock index futures, noting that the annualized discount rates of the main contracts of the Shanghai Stock Exchange 50, CSI 300, CSI 500, and CSI 1000 stock index futures were 3.86%, 5.27%, 15.75%, and 14.40%, respectively, on July 4, 2025[25] - The report provides data on institutional attention and the Dragon and Tiger list, noting that the stocks with the highest net inflows from institutional seats were Shenzhou Cells, Xice Testing, Longyang Electronics, Guangsheng Tang, Nanling Technology, Rejing Biology, Desheng Technology, Yihong New Materials, Xuedilong, and Canning Power[27][30][33] - The report includes data on the net inflows and outflows of stocks from the Shanghai-Hong Kong Stock Connect, noting that the stocks with the highest net inflows were Beijing New Pharmaceuticals, Hengbao Shares, Bomin Electronics, Longyang Electronics, Guangsheng Tang, and Shenzhou Cells[34]